Ted Knous
Directeur/Membre du Conseil chez University of Kansas
Profil
Ted Knous is currently working as Vice Chancellor at the University of Kansas.
He previously worked as Director at Igxbio, Inc. from 1976 to 1979.
Dr. Knous obtained a doctorate degree from the University of Minnesota in 1979.
Postes actifs de Ted Knous
| Sociétés | Poste | Début |
|---|---|---|
| University of Kansas | Directeur/Membre du Conseil | 31/03/2009 |
Anciens postes connus de Ted Knous
| Sociétés | Poste | Fin |
|---|---|---|
Igxbio, Inc.
 Igxbio, Inc. Pharmaceuticals: MajorHealth Technology Igxbio, Inc. develops DNA immunotherapies for HIV infection. It offers GenePro, a DNA therapeutic incorporating a DNA composition that yields high levels of gene expression and non-infectious HIV protein production, and induces an antibody and cellular immune response in animal models, including non-human primates. The company was founded in 2002 and is headquartered in Fairway, KS. | Directeur/Membre du Conseil | - |
Formation de Ted Knous
| University of Minnesota | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Igxbio, Inc.
Igxbio, Inc. Pharmaceuticals: MajorHealth Technology Igxbio, Inc. develops DNA immunotherapies for HIV infection. It offers GenePro, a DNA therapeutic incorporating a DNA composition that yields high levels of gene expression and non-infectious HIV protein production, and induces an antibody and cellular immune response in animal models, including non-human primates. The company was founded in 2002 and is headquartered in Fairway, KS. | Health Technology |
